LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN AXIAL SPONDYLOARTHRITIS IS HIGHER: DATA FROM TURKBIO

dc.contributor.authorKoca, SS
dc.contributor.authorPehlivan, Y
dc.contributor.authorAkar, S
dc.contributor.authorSenel, S
dc.contributor.authorGuler, AA
dc.contributor.authorSosyal, O
dc.contributor.authorYazici, A
dc.contributor.authorYilmaz, S
dc.contributor.authorSagir, RP
dc.contributor.authorInanc, N
dc.contributor.authorKaratas, A
dc.contributor.authorCetin, GY
dc.contributor.authorAtagündüz, P
dc.contributor.authorOnen, F
dc.date.accessioned2025-04-10T10:37:14Z
dc.date.available2025-04-10T10:37:14Z
dc.identifier.e-issn1468-2060
dc.identifier.issn0003-4967
dc.identifier.urihttp://hdl.handle.net/20.500.14701/42913
dc.language.isoEnglish
dc.titleLONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN AXIAL SPONDYLOARTHRITIS IS HIGHER: DATA FROM TURKBIO
dc.typeMeeting Abstract

Files